Post-Traumatic Seizures

Reviewed and revised 10 October 2014

OVERVIEW

  • Post-Traumatic Seizures (PTS) occur in ~ 15% of patients with blunt severe TBI
  • higher risk in children
  • most occur within 48 hours
  • most studies suggest that compliance with BTF guidelines (see below) regarding PTS prophylaxis is poor, most likely reflecting the paucity of evidence

CLASSIFICATION

  • immediate seizure, <24 h (1-4% of TBI)
  • early seizure, <7 days (4-25% of TBI)
  • late seizure, > 7 days (9-42% of TBI)

RISK FACTORS FOR POST-TRAUMATIC SEIZURES

From BTF guidelines:

  • GCS<10
  • Cortical contusion
  • Depressed skull fracture
  • Subdural, epidural or intracerebral haematoma
  • Penetrating head wound
  • Seizure within 24 hours of injury

IMPLICATIONS

  • an ‘impact seizure’ at the time of TBI is often benign
  • PTS can contribute to secondary injury:
    — increased metabolism
    — increased neurotransmitter release
    — increased intracranial pressure
  • potential for longterm sequelae:
    — abnormal cognition and behaviour
    — adverse effects on employment and recreation

PROPHYLAXIS

Overview

  • Anti-epileptic drugs (AEDs) prevent early seizures (NNT = 10, Cochrane Review) but have no impact on outcome or mortality
  • AEDs in the acute phase of TBI (first 7 days) do not reduce the incidence of PTS in the longterm and are not recommended for this purpose
  • AEDs can have significant side-effects

Indications for AEDs

  • clinical or EEG evidence of post-traumatic seizures
  • high-risk of post-traumatic seizures (controversial; BTF guidelines suggest the presence of at least 1 risk factor)

Phenytoin is the first line agent (BTF Guidelines)

  • proven efficacy in partial and generalized seizures
  • loading dose 15–20 mg/kg over 30 min followed by 100 mg IV three times daily for 7 days titrated to plasma levels
    — phenytoin cannot be given enterally at the same time as enteral nutrition
  •  a second AED can be instituted if seizures persist

Levetiracetam may be an appropriate alternative

  • 20mg/kg IV followed by 1000mg q12h for 7 days
  • Szaflarski et al, 2010: a ‘single-blinded’ RCT of 53 patients compared levetiracetam and phenytoin, found that phenytoin associated with
    — worsening neurologic function (GOSE at 6 months)
    — more frequent adverse drug events

CCC Neurocritical Care Series

Journal articles

  • Bratton SL, et al. Guidelines for the Management of Severe Traumatic Brain Injury, 3rd edition: Antiseizure prophylaxis. Journal of Neurotrauma 2007;24(S1):S82-S86
  • Khan AA, Banerjee A. The role of prophylactic anticonvulsants in moderate to severe head injury. Int J Emerg Med. 2010 Jul 22;3(3):187-91. PMC2926870
  • Szaflarski JP et al. Prospective, randomized, single blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12:165-172. PMID: 19898966
  • Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia 2003;44 (Suppl 10):18-20.
  • Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502. PMID: 2115976
  • Thompson K, Pohlmann-Eden B, Campbell LA. Pharmacological treatments for preventing epilepsy following traumatic head injury (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 6. Art. [Free Full Text – protocol only is published as of 10/10/2014]

FOAM and web resources

Critical Care

Compendium

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.